Synonyms: MMV687696 | Q203
Compound class:
Synthetic organic
Comment: Telacebec is a first-in-class imidazopyridine amide that inhibits the mycobacterial cytochrome bc1 complex [3]. It is being clinically evaluated as a treatment for tuberculosis (TB).
Telacebec was one of the compounds with activity against Mycobacterium tuberculosis included in the Medicines for Malaria Venture (MMV) Pathogen Box (see MMVOpen for futher details). |
|
Bioactivity Comments |
Telacebec has narrow-spectrum antibacterial activity that is specifically against Mycobacterium tuberculosis [3]. The MIC50 for in vitro antimycobacterial activity is 2.7 nM against Mycobacterium tuberculosis H37Rv and the MIC90 is 0.43-28 nM against a panel of multidrug-resistant (MDR) and extensively drug-resistant (XDR) M. tuberculosis clinical isolates [3]. Telacebec has been shown to have synergistic activity when combined with PBTZ169 [2]. |